Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions

References

• Runciman WB, Roughead EE, Semple SJ, et al. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.
   PubMed Web of Science ®Google Scholar
• Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, et al. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol. 2015;29(1):106–111.
   PubMed Web of Science ®Google Scholar
• Zhang M, Holman CD, Preen DB, et al. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol. 2007;63(2):163–170.
   PubMed Web of Science ®Google Scholar
• Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002-2008. Aust New Zealand Health Policy. 2009;6(1):18.
   PubMedGoogle Scholar
• Australian Institute of Health and Welfare - Adverse Events treated in hospital 2018 [cited 2021]. Available from: https://www.aihw.gov.au/reports/australias-health/australias-health-2018/contents/indicators-of-australias-health/adverse-events-treated-in-hospital.
   Google Scholar
• Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.
   PubMed Web of Science ®Google Scholar
• Wilson RM, Runciman WB, Gibberd RW, et al. The quality in Australian health care study. Med J Aust. 1995;163(9):458–471.
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare - Australian Hospital statistics 2012 [cited 2021]. Available from: https://www.aihw.gov.au/reports/hospitals/australian-hospital-statistics-2011-12/.
   Google Scholar
• Australian Government Department of Health. Therapeutic goods administration: reporting adverse events 2019 [updated Oct 2019]. [ cited 2021]. Available from: https://www.tga.gov.au/reporting-adverse-events.
   Google Scholar
• Medicines and vaccines post-market vigilance. statistics for 2017 2018 [updated 2018 Aug 10]. Available from: https://www.tga.gov.au/medicines-and-vaccines-post-market-vigilance-statistics-2017.
   Google Scholar
• Li R, Curtis K, Zaidi STR, et al. Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis. Expert Opin Drug Saf. 2020;19(6):747–753.
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396.
   PubMed Web of Science ®Google Scholar
• Emergency Department Short Stay Units. In: Health N, editor. 2019.
   Google Scholar
• The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD) 2003 [cited 2021]. Available from: https://www.who.int/classifications/atcddd/en/.
   Google Scholar
• Medical Dictionary for Regulatory Activities (MedDRA) 2021 [cited 2021]. Available from: https://www.meddra.org/.
   Google Scholar
• Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–1259.
   PubMed Web of Science ®Google Scholar
• The use of the WHO–UMC system for standardised case causality assessment: Uppsala monitoring centre; 2012 [cited 2021 Jun 3]. Available from: https://www.who.int/publications/m/item/WHO-causality-assessment
   Google Scholar
• HALLAS J, Harvald B, Gram LF; Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.
   PubMed Web of Science ®Google Scholar
• Therapeutic Goods Administration Database of Adverse Event Notification (DAEN) 2018 [cited 2021]. Available from: https://www.tga.gov.au/database-adverse-event-notifications-daen.
   Google Scholar
• Claydon-Platt K, Manias E, Dunning T. Medication-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study. Diabetes Res Clin Pract. 2012;97(2):223–230.
   PubMed Web of Science ®Google Scholar
• Helldén A, Bergman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging. 2009;26(7):595–606.
   PubMed Web of Science ®Google Scholar
• Rydberg DM, Holm L, Engqvist I, et al. Adverse drug reactions in a tertiary care emergency medicine ward - prevalence, preventability and reporting. PLoS One. 2016;11(9):e0162948.
   PubMed Web of Science ®Google Scholar
• Cho H, Choi J, Kim YS, et al. Prevalence and predictors of potentially inappropriate prescribing of central nervous system and psychotropic drugs among elderly patients: a national population study in Korea. Arch Gerontol Geriatr. 2018;74:1–8.
   PubMed Web of Science ®Google Scholar
• Hedna K, Hakkarainen KM, Gyllensten H, et al. Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol. 2015;71(12):1525–1533.
   PubMed Web of Science ®Google Scholar
• ICH harmonized tripartite guideline clinical safety data management: definitions and standards for expedited reporting E2A: international conference on harmonization; 1994 [cited 2019]. Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E2A/Step4/E2A_Guideline.pdf.
   Google Scholar
• Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol. 1992;33(1):61–68.
   PubMed Web of Science ®Google Scholar
• Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French pharmacovigilance centres. BMJ (Clin Res Ed). 2000;320(7241):1036.
   PubMed Web of Science ®Google Scholar
• Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14(1):10.
   PubMed Web of Science ®Google Scholar
• Plessis L, Gomez A, Garcia N, et al. Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection. Eur J Clin Pharmacol. 2017;73(6):751–758.
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Lima S, Zampieri ME, et al. Filling quality of the reports of adverse drug reactions received at the pharmacovigilance centre of Sao Paulo (Brazil): missing information hinders the analysis of suspected associations. Expert Opin Drug Saf. 2017;16(12):1329–1334.
   PubMed Web of Science ®Google Scholar
• Mirbaha F, Shalviri G, Yazdizadeh B, et al. Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach. Implement Sci. 2015;10(1):110.
   PubMed Web of Science ®Google Scholar
• Vallano A, Cereza G, Pedròs C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653–658.
   PubMed Web of Science ®Google Scholar
• Li R, Zaidi STR, Chen T, et al. Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: a systematic review. Pharmacoepidemiol Drug Saf. 2020;29(1):1–8.
   PubMed Web of Science ®Google Scholar
• Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother. 1999;33(2):236–240.
   PubMed Web of Science ®Google Scholar
• McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36(9):1331–1336.
   PubMed Web of Science ®Google Scholar
• Patel NS, Patel TK, Patel PB, et al. Hospitalizations due to preventable adverse reactions-a systematic review. Eur J Clin Pharmacol. 2017;73(4):385–398.
   PubMed Web of Science ®Google Scholar
• Marrero O, Hung EY, Hauben M. Seasonal and geographic variation in adverse event reporting. Drugs Real World Outcomes. 2016;3(3):297–306.
   PubMedGoogle Scholar